Nu Skin Enterprises Stock (NYSE:NUS), Trade Ideas

Nu Skin Enterprises

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Long Ideas

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

SNAX

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 4 Risk Off Stocks That May Explode In February

Intraday Update

Movers

AMWL

APPN

AUPH

CETY

CGNX

CHNR

CNVS

DNOW

DTSS

DWAC

ELWS

EPAM

EXPR

FROG

FSLY

IFBD

INFA

INOD

JXJT

LYFT

MANU

NNOX

NSIT

ORGS

PEGA

PENN

PLCE

PTEN

RNLX

ROMA

RVSN

SABR

SHAK

SLVM

SOUN

SPWR

TELO

TWLO

UDMY

ULBI

UPXI

ZBRA

Shares of  Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

CSCO

ENGN

GRNQ

MHUA

Shares of  AppLovin Corporation (NASDAQ: APP) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial

Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Nu Skin Enterprises Inc

Nuveen ESG 1-5 Year U.S. Aggregate Bond ETF

Nuveen Ultra Short Income ETF

Nuveen ESG Small-Cap ETF

Nationwide Nasdaq-100 Risk-Managed Income ETF

NAUTILUS MINERALS INC ORD by Nautilus Minerals Inc.

NEW SOURCE ENGY PFD UTS by New Source Energy Partners LP

Dividends

Navigating Challenges and Investor Rewards: Nu Skin Enterprises Ensures Steady Distribution amidst Changing Profits

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>Herbalife Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>)</h3>
<ul>
<li>On Feb. 14, Herbalife reported mixed fourth-quarter financial results. The company&rsquo;s stock fell around 32% over the past five days and has a <a href="https://www.benzinga.com/quote/HLF">52-week low of $6.68 </a>.</li>
<li>RSI Value: 28.29</li>
<li>HLF Price Action: Shares of Herbalife gained 2.4% to close at $8.26 on Tuesday.</li>
</ul>
<h3>Universal Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uvv#NYSE">UVV</a>)</h3>
<ul>
<li>On Feb. 7, Universal posted third-quarter earnings of $2.12 per share, up from $1.67 per share in the year-ago period. George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal, stated, &quot;Universal Corporation again delivered strong financial and operational performance in the third quarter of fiscal year 2024. Operating income and net income for the quarter were up 13% and 28%, respectively, relative to the third quarter of fiscal year 2023, which helped increase operating income and net income for the nine months of fiscal year 2024 by 20% and 13%, respectively, compared to the same period last fiscal year.&quot; The company&rsquo;s stock fell around 17% over the past month. It <a href="https://www.benzinga.com/quote/UVV"> has a 52-week low </a> of $44.40.</li>
<li>RSI Value: 22.77</li>
<li>UVV Price Action: Shares of Universal Corporation fell 0.8% to close at $49.35 on Tuesday.</li>
</ul>
<h3>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>)</h3>
<ul>
<li>On Feb. 14, Nu Skin reported fourth-quarter financial results. &quot;While we continue to work toward our long-term vision of becoming the world&rsquo;s leading integrated beauty and wellness platform, our progress was impacted by persistent macro-economic pressures and disruptions associated with transforming our business,&quot; said Ryan Napierski, Nu Skin president and CEO. The company&rsquo;s stock fell around 28% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/NUS"> low of $12.89.</a></li>
<li>RSI Value: 21.93</li>
<li>NUS Price Action: Shares of Nu Skin fell 4.8% to close at $13.03 on Tuesday.</li>
</ul>
<h3>Stryve Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snax#NASDAQ">SNAX</a>)</h3>
<ul>
<li>On Feb. 1, Stryve Foods announced a significant expansion in its distribution network. The company&rsquo;s shares lost around 7% over the past five days. The company&rsquo;s 52-week low is $1.35.</li>
<li>RSI Value: 26.87</li>
<li>SNAX Price Action: Shares of Stryve Foods fell 6.3% to close at $1.35 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling </a>

Thursday marks the last chance for investors to receive the next dividend payout from Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 6 cents per share. On Friday, Nu Skin Enterprises will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 6 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own NUS as of the end of Thursday's session are eligible to receive the 6 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on March 06, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Nu Skin Enterprises's Ex-Dividend Date Is Friday, Here's What You Need To Know

Shares of Herbalife Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>) fell sharply in today&rsquo;s session following <a href="https://www.benzinga.com/quote/HLF/earnings">weak quarterly earnings</a>.
Herbalife posted adjusted earnings of 28 cents per share, missing market estimates of 39 cents per share. The company&rsquo;s quarterly sales came in at $1.22 billion versus expectations of $1.19 billion.
Herbalife shares dipped 35.7% to $7.55 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>JX Luxventure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jxjt#NASDAQ">JXJT</a>) shares jumped 377% to $6.21 following H1 results.</li>
<li>Dunxin Financial Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxf#NYSE">DXF</a>) surged 204% to $1.11 after gaining around 5% on Wednesday.</li>
<li>China Natural Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chnr#NASDAQ">CHNR</a>) jumped 143% to $2.68 after gaining around 10% on Wednesday.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) rose 101% to $29.23.</li>
<li>Nano-X Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nnox#NASDAQ">NNOX</a>) shares climbed 54.7% to $9.84. Nvidia reported a 59,632 share stake in Nano X Imaging.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) gained 54% to $0.1710.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) gained 53% to $3.4499. According to data from Benzinga Pro, BlackRock reported a 5.6% passive stake in SoundHound AI after the market close. Traders also appear to be circling a filing from Nvidia in which the company disclosed positions in several companies, including SoundHound AI.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) climbed 30.2% to $0.4362. Orgenesis 10% owner Jacob Safier acquired a total of 365,140 shares at an average price of $0.58.</li>
<li>Pegasystems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pega#NASDAQ">PEGA</a>) jumped 27.8% to $64.84 after the company reported better-than-expected fourth-quarter financial results and issued FY24 EPS and revenue guidance above estimates.</li>
<li>JFrog Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frog#NASDAQ">FROG</a>) shares gained 27% to $47.09 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS and revenue guidance above estimates.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) rose 26% to $1.1800.</li>
<li>American Well Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amwl#NASDAQ">AMWL</a>) jumped 25% to $1.39 following quarterly results.</li>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) gained 25% to $11.24. DataSea announced a $30 million 5G multimodal communication technology service agreement.</li>
<li>AppLovin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/app#NASDAQ">APP</a>) rose 22% to $57.16 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Ultralife Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulbi#NASDAQ">ULBI</a>) gained 21.4% to $9.60 following upbeat quarterly results.</li>
<li>Shake Shack Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shak#NYSE">SHAK</a>) rose 18.6% to $92.60 after the company reported better-than-expected quarterly financial results and issued guidance.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) jumped 18.6% to $51.65 after the company announced the U.S. Securities and Exchange Commission declared its registration statement on Form S-4 effective.</li>
<li>Sylvamo Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slvm#NYSE">SLVM</a>) gained 18.5% to $53.94 following upbeat earnings.</li>
<li>DNOW Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dnow#NYSE">DNOW</a>) jumped 18.4% to $11.62 following strong quarterly results.</li>
<li>Express, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/expr#NYSE">EXPR</a>) climbed 18.1% to $2.4111.</li>
<li>Organon &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogn#NYSE">OGN</a>) shares rose 16.5% to $19.07 after the company reported better than expected Q4 2023 earnings and issued 2024 guidance.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) shares surged 15.9% to $1.25 after falling 6% on Wednesday.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) gained 15.2% to $6.76.</li>
<li>Organon &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogn#NYSE">OGN</a>) rose 14.9% to $18.80 after the company reported better than expected fourth quarter earnings and issued 2024 guidance.</li>
<li>Zebra Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zbra#NASDAQ">ZBRA</a>) rose 14% to $288.44 after the company reported fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Appian Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/appn#NASDAQ">APPN</a>) climbed 13.8% to $37.97 after the company reported fourth-quarter financial results above estimates.</li>
<li>Zebra Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zbra#NASDAQ">ZBRA</a>) rose 12.7% to $285.24 after the company reported fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Informatica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/infa#NYSE">INFA</a>) gained 12.6% to $33.91 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Patterson-UTI Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pten#NASDAQ">PTEN</a>) rose 12.3% to $11.61 following strong sales.</li>
<li>Reliance Steel &amp; Aluminum Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rs#NYSE">RS</a>) rose 10.4% to $325.15 after the company reported fourth-quarter earnings above estimates and issued above-consensus first-quarter FY24 adjusted EPS.</li>
<li>EPAM Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/epam#NYSE">EPAM</a>) gained 10.3% to $288.44 after the company reported fourth-quarter financial results and issued first-quarter revenue guidance above estimates.</li>
<li>Cognex Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgnx#NASDAQ">CGNX</a>) rose 9.8% to $39.70 following upbeat earnings.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) shares jumped 8.8% to $4.64 after the company announced raising $175 million in new capital financing from TotalEnergies and Global Infrastructure Partners and fourth-quarter financial results below estimates.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) rose 8.6% to $17.82. Lyft recently reported fourth-quarter financial results and issued guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) fell 45.7% to $0.0862 following second-quarter results.</li>
<li>Beamr Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmr#NASDAQ">BMR</a>) fell 44% to $9.00.</li>
<li>Earlyworks Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) shares fell 39.1% to $0.7979.</li>
<li>Upexi, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upxi#NASDAQ">UPXI</a>) shares declined 30.4% to $0.96 following weak quarterly results.</li>
<li>Telomir Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/telo#NASDAQ">TELO</a>) shares fell 30.1% to $8.31 after jumping around 70% on Wednesday.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) shares tumbled 29.2% to $16.67 after the company reported mixed fourth-quarter financial results.</li>
<li>Cineverse Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnvs#NASDAQ">CNVS</a>) shares fell 27.2% to $1.7120 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Aurinia Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auph#NASDAQ">AUPH</a>) fell 26.1% to $5.89 after the company reported mixed fourth-quarter financial results and said it did not find a buyer after conducting a strategic business review.</li>
<li>Clean Energy Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cety#NASDAQ">CETY</a>) dipped 26% to $0.7989.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) fell 25.4% to $0.9001 after the company posted weak quarterly sales.</li>
<li>Innodata Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inod#NASDAQ">INOD</a>) fell 25.2% to $9.16 after Wolfpack Research issued a report on the company and said it is short the stock.</li>
<li>Sabre Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabr#NASDAQ">SABR</a>) dipped 23.3% to $3.3850 after the company reported mixed quarterly financial results.</li>
<li>Udemy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/udmy#NASDAQ">UDMY</a>) fell 20.8% to $11.08 after the company reported fourth-quarter financial results.</li>
<li>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>) shares fell 18.8% to $14.15 after the company reported fourth-quarter financial results.</li>
<li>West Pharmaceutical Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wst#NYSE">WST</a>) fell 18.5% to $332.37 after the company reported mixed fourth-quarter financial results and issued 2024 adjusted EPS and sales guidance below estimates.</li>
<li>Twilio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) dipped 13.8% to $62.29 after the company reported fourth-quarter financial results.</li>
<li>The Manitowoc Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtw#NYSE">MTW</a>) fell 12.6% to $14.36 following weak earnings.</li>
<li>Manchester United plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/manu#NYSE">MANU</a>) fell 12.1% to $18.90.</li>
<li>Hanesbrands Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hbi#NYSE">HBI</a>) fell 11.6% to $4.17 following weak results.</li>
<li>PENN Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/penn#NASDAQ">PENN</a>) fell 10.2% to $20.17 following weak results.</li>
<li>Insight Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nsit#NASDAQ">NSIT</a>) dipped 5.5% to $182.10 after the company reported fourth-quarter financial results and issued FY24 EPS guidance below estimates.</li>
<li>Deere &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/de#NYSE">DE</a>) fell 4.7% to $366.79 after the company reported first-quarter earnings and lowered FY24 net income guidance.</li>
<li>Rollins, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rol#NYSE">ROL</a>) fell 4.1% to $42.42 following quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37150356/disney-progressive-leidos-and-more-cnbcs-final-trades"> Disney, Progressive, Leidos And More: CNBC&#39;s &#39;Final Trades&#39;</a>

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

WIIM

Nu Skin shares are trading lower after the company reported Q4 financial results.

Shares of AppLovin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/app#NASDAQ">APP</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/02/37145288/applovin-q4-earnings-revenue-beat-estimates-expands-buy-back-program-by-1-25b">fourth-quarter financial results</a>.
AppLovin reported quarterly earnings of 49 cents per share which beat the analyst consensus estimate of 36 cents. The company reported quarterly sales of $953.26 million, beating the analyst consensus estimate of $928.17 million.
AppLovin shares jumped 22.3% to $57.30 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>China Natural Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chnr#NASDAQ">CHNR</a>) gained 409% to $5.60 in pre-market trading after gaining around 10% on Wednesday.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) shares jumped 70.2% to $1.89 in pre-market trading after surging around 19% on Wednesday.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) gained 69.8% to $3.83 in pre-market trading. According to data from Benzinga Pro, BlackRock reported a 5.6% passive stake in SoundHound AI after the market close. Traders also appear to be circling a filing from Nvidia in which the company disclosed positions in several companies, including SoundHound AI.</li>
<li>Nano-X Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nnox#NASDAQ">NNOX</a>) shares rose 46.2% to $9.30 in pre-market trading. Nvidia reported a 59,632 share stake in Nano X Imaging.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) shares surged 38% to $1.49 in pre-market trading after falling 6% on Wednesday.</li>
<li>Dunxin Financial Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxf#NYSE">DXF</a>) shares gained 34.2% to $0.49 in pre-market trading after gaining around 5% on Wednesday.</li>
<li>Greenpro Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grnq#NASDAQ">GRNQ</a>) shares rose 24.3% to $1.74 in pre-market trading after gaining around 23% on Wednesday.</li>
<li>JFrog Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frog#NASDAQ">FROG</a>) shares gained 22.1% to $44.92 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS and revenue guidance above estimates.</li>
<li>Informatica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/infa#NYSE">INFA</a>) gained 17.3% to $35.34 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares dipped 40.4% to $0.0945 in pre-market trading following second-quarter results.</li>
<li>Cineverse Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnvs#NASDAQ">CNVS</a>) shares fell 31.9% to $1.60 in pre-market trading after the company reported worse-than-expected third-quarter financial results.</li>
<li>Upexi, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upxi#NASDAQ">UPXI</a>) shares declined 29.5% to $0.9724 in pre-market trading following weak quarterly results.</li>
<li>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>) shares fell 24% to $13.25 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) shares tumbled 23.1% to $18.10 in pre-market trading after the company reported mixed fourth-quarter financial results.</li>
<li>enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) shares fell 13.3% to $14.30 in pre-market trading. enGene shares jumped around 116% on Wednesday after the company announced an oversubscribed $200 million private placement financing.</li>
<li>Herbalife Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>) shares declined 12.3% to $10.30 in pre-market trading following weak quarterly earnings.</li>
<li>Twilio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) dipped 12.1% to $63.51 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li>Telomir Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/telo#NASDAQ">TELO</a>) shares fell 10.7% to $10.64 in pre-market trading after jumping around 70% on Wednesday.</li>
<li>Cisco Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csco#NASDAQ">CSCO</a>) fell 5.2% to $47.67 in pre-market trading following second-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37149816/cisco-deere-and-3-stocks-to-watch-heading-into-thursday"> Cisco, Deere And 3 Stocks To Watch Heading Into Thursday </a>

U.S. stock futures were higher this morning, with the Dow futures trading higher by around 70 points on Thursday.
Shares of Cisco Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csco#NASDAQ">CSCO</a>) fell in today&rsquo;s pre-market trading following <a href="https://www.benzinga.com/news/earnings/24/02/37141493/cisco-q2-earnings-and-revenue-beat-cuts-5-of-global-workforce">second-quarter results</a>.
Cisco reported better-than-expected second-quarter financial results but issued weak full-year 2024 guidance. The company also announced a restructuring plan to cut approximately 5% of its global workforce.
Cisco Systems shares fell 5.2% to $47.68 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>) shares dipped 24% to $13.25 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) shares fell 23.1% to $18.10 in pre-market trading after the company reported mixed fourth-quarter financial results.</li>
<li>enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) shares declined 13.3% to $14.30 in pre-market trading. enGene shares jumped around 116% on Wednesday after the company announced an oversubscribed $200 million private placement financing.</li>
<li>Herbalife Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>) shares fell 12.3% to $10.30 in pre-market trading following weak quarterly earnings.</li>
<li>Twilio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) fell 12.1% to $63.51 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li>Telomir Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/telo#NASDAQ">TELO</a>) tumbled 10.7% to $10.64 in pre-market trading after jumping around 70% on Wednesday.</li>
<li>Larimar Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrmr#NASDAQ">LRMR</a>) fell 7.9% to $11.01 in pre-market trading after gaining over 36% on Wednesday. Larimar Therapeutics priced the public offering of 17.16 million shares at $8.74/share for gross proceeds of approximately $150 million.</li>
<li>Rollins, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rol#NYSE">ROL</a>) fell 6.3% to $41.48 in pre-market trading following quarterly results.</li>
<li>Albemarle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alb#NYSE">ALB</a>) shares fell 5.6% to $108.00 in pre-market trading following quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37149861/investor-sentiment-improves-dow-jumps-over-150-points"> Investor Sentiment Improves; Dow Jumps Over 150 Points</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

CCSO

Larimar Therapeutics, Inc. - Common Stock

LRMR

Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Guidance

Nu Skin Enterprises Expects 2024 Revenue Of $1.73B-$1.87B (Est $2.012B), Adj EPS Of $0.95-$1.35 (Est $2.05)

The quarterly cash dividend of $0.06 per share&nbsp;will be paid on March 6, 2024, to shareholders of record on Feb. 26, 2024.&nbsp;The company said it is&nbsp;rebalancing dividend payout ratio to be in line with or better than industry peers.&nbsp;

Nu Skin Enterprises Updates Capital Allocation Priorities; Cuts Quarterly Cash Dividend From $0.39 To $0.06 Per Share

Nu Skin Enterprises Expects Q1 Revenue Of $400M-$435M (Est $479.67M), Adj EPS Of $0.00-$0.10 (Est $0.34)

Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) reported its Q4 earnings results on Wednesday, February 14, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Nu Skin Enterprises beat estimated earnings by 32.14%, reporting an EPS of $0.37 versus an estimate of $0.28.
Revenue was down $33.70 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.06 which was followed by a 9.45% drop in the share price the next day.
Here's a look at Nu Skin Enterprises's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.62</td>
<td>0.53</td>
<td>0.33</td>
<td>0.53</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.56</td>
<td>0.54</td>
<td>0.37</td>
<td>0.89</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>520.09M</td>
<td>512.35M</td>
<td>477.48M</td>
<td>542.32M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>498.77M</td>
<td>500.26M</td>
<td>481.46M</td>
<td>522.34M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Nu Skin Enterprises <a href="https://www.benzinga.com/quote/NUS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Nu Skin Enterprises: Q4 Earnings Insights

Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.28 by 32.14 percent. The company reported quarterly sales of $488.64 million which beat the analyst consensus estimate of $476.39 million by 2.57 percent. This is a 6.45 percent decrease over sales of $522.34 million the same period last year.

Earnings Beats

Nu Skin Enterprises Q4 2023 Adj EPS $0.37 Beats $0.28 Estimate, Sales $488.64M Beat $476.39M Estimate

ACGL

ADPT

AEMD

ATEX

ATMU

ATUS

AVNT

AVTR

AYTU

BLIN

BXMT

BYRN

CCRD

CEVA

CHEF

CNDT

CNHI

CNXN

CRWS

CSPI

EPRT

EQIX

FBRT

FCPT

GLDD

GNRC

GOLD

GPMT

HCSG

HUBS

ISSC

KRNT

MCRI

MITQ

MMLP

NATL

NMIH

NRDS

NTST

PGRE

PLMR

POCI

PYPD

QIPT

RBBN

Earnings Scheduled For February 14, 2024

Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here's what investors need to know before the announcement.
Analysts estimate that Nu Skin Enterprises will report an earnings per share (EPS) of $0.28. 
Nu Skin Enterprises bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.06, which was followed by a 9.45% drop in the share price the next day.
Here's a look at Nu Skin Enterprises's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.62</td>
<td>0.53</td>
<td>0.33</td>
<td>0.53</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.56</td>
<td>0.54</td>
<td>0.37</td>
<td>0.89</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.45%</td>
<td>-7.63%</td>
<td>-3.32%</td>
<td>-4.21%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707832921_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Nu Skin Enterprises were trading at $18.72 as of February 09. Over the last 52-week period, shares are down 58.75%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/NUS/earnings">To track all earnings releases for Nu Skin Enterprises visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Nu Skin Enterprises's Earnings Outlook

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings" target="_blank">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including&nbsp;by analyst accuracy. Here&#39;s a look at the most recent high-yield dividend&nbsp;stock ratings from the most accurate Wall Street analysts, according to Benzinga&#39;s&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock&nbsp;</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Ratings</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>)</h3>
<ul>
<li>Dividend Yield: 8.53%</li>
<li>DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating and cut the price target from $29 to $21 on Jan. 5, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating and slashed the price target from $35 to $27 on Oct. 16, 2023. This analyst has an accuracy rate of 80%.</li>
<li>Recent News: Nu Skin Enterprises reported fourth-quarter preliminary revenue slightly above guidance with full financial results to be announced on Feb. 14.</li>
</ul>
<h3>PepsiCo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pep#NASDAQ">PEP</a>)</h3>
<ul>
<li>Dividend Yield: 2.99%</li>
<li>JP Morgan analyst Andrea Teixeira downgraded the stock from Overweight to Neutral and cut the price target from $185 to $176 on Dec. 19, 2023. This analyst has an accuracy rate of 61%.</li>
<li>Morgan Stanley analyst Dara Mohsenian maintained an Equal-Weight rating and slashed the price target from $210 to $190 on Oct. 11, 2023. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: PepsiCo named Ram Krishnan as CEO for PepsiCo Beverages North America.</li>
</ul>
<h3>Target Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgt#NYSE">TGT</a>)</h3>
<ul>
<li>Dividend Yield: 3.16%</li>
<li>Citigroup analyst Paul Lejuez maintained a Neutral rating and raised the price target from $117 to $142 on Nov. 16, 2023. This analyst has an accuracy rate of 67%.</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating on the stock and increased the price target from $130 to $141 on Nov. 16, 2023. This analyst has an accuracy rate of 80%.</li>
<li>Recent News: Target named Michael Fiddelke, who has served as CFO since Nov. 1, 2019, as its COO, effective Feb. 4, 2024.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/24/01/36756566/top-3-tech-stocks-that-may-plunge-this-month"> Top 3 Tech Stocks That May Plunge This Month</a>

Price Target

Analyst Ratings

Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings" target="_blank">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including&nbsp;by analyst accuracy. Here&#39;s a look at the most recent high-yield dividend&nbsp;stock ratings from the most accurate Wall Street analysts, according to Benzinga&#39;s&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock&nbsp;</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Ratings</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>)</h3>
<ul>
<li>Dividend Yield: 8.21%</li>
<li>DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating and cut the price target from $29 to $21 on Jan. 5, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating and slashed the price target from $35 to $27 on Oct. 16, 2023. This analyst has an accuracy rate of 82%.</li>
<li>Recent News: Nu Skin Enterprises reported fourth-quarter preliminary revenue slightly above guidance with full financial results to be announced on Feb. 14.</li>
</ul>
<h3>B&amp;G Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bgs#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 7.22%</li>
<li>Piper Sandler analyst Michael Lavery downgraded the stock from Neutral to Underweight and cut the price target from $14 to $8 on Oct. 4, 2023. This analyst has an accuracy rate of 71%.</li>
<li>TD Cowen analyst Robert Moskow maintained an Underperform rating and lowered the price target from $10 to $9.5 on Sept. 19, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: B&amp;G Foods, during November, posted upbeat earnings for its third quarter, while sales missed estimates.</li>
</ul>
<h3>Kimberly-Clark Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmb#NYSE">KMB</a>)</h3>
<ul>
<li>Dividend Yield: 3.83%</li>
<li>B of A Securities analyst Anna Lizzul downgraded the stock from Neutral to Underperform and cut the price target from $135 to $115 on Dec. 15, 2023. This analyst has an accuracy rate of 67%.</li>
<li>Barclays analyst Lauren Lieberman maintained an Equal-Weight rating and raised the price target from $122 to $123 on Oct. 26, 2023. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: Kimberly-Clark, during October, reported third-quarter sales growth of 2% Y/Y to $5.13 billion, missing the analyst consensus estimate of $5.15 billion.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/24/01/36552256/hewlett-packard-enterprise-hologic-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session"> Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session</a>

Beat Inflation With These 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts

Nu Skin Enterprises Reports Q4 Preliminary Revenue Slightly Above Guidance With Full Financial Results To Be Announced Feb. 14

DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) with a Neutral and lowers the price target from $29 to $21.

DA Davidson Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $21

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings" target="_blank">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including&nbsp;by analyst accuracy. Here&#39;s a look at the most recent high-yield dividend&nbsp;stock ratings from the most accurate Wall Street analysts, according to Benzinga&#39;s&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock&nbsp;</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Ratings</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3>Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>)</h3>
<ul>
<li>Dividend Yield: 7.96%</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating on the stock and cut the price target from $35 to $27 on Oct. 16, 2023. This analyst has an accuracy rate of 82%.</li>
<li>DA Davidson analyst Linda Bolton Weiser reiterated a Neutral rating and lowered the price target from $38 to $29 on Aug. 3, 2023. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: Nu Skin Enterprises, last month, posted weaker-than-expected results for its third quarter.</li>
</ul>
<h3>B&amp;G Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bgs#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 7.02%</li>
<li>Piper Sandler analyst Michael Lavery downgraded the stock from Neutral to Underweight and cut the price target from $14 to $8 on Oct. 4, 2023. This analyst has an accuracy rate of 71%.</li>
<li>TD Cowen analyst Robert Moskow maintained an Underperform rating and lowered the price target from $10 to $9.5 on Sept. 19, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: B&amp;G Foods, last month, posted upbeat earnings for its third quarter, while sales missed estimates.</li>
</ul>
<h3>Conagra Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cag#NYSE">CAG</a>)</h3>
<ul>
<li>Dividend Yield: 4.92%</li>
<li>Jefferies analyst Rob Dickerson maintained a Hold rating and cut the price target from $30 to $28 on Oct. 6, 2023. This analyst has an accuracy rate of 70%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and lowered the price target from $38 to $37 on Aug. 21, 2023. This analyst has an accuracy rate of 81%.</li>
<li>Recent News: On Oct. 5, ConAgra Brands reported upbeat earnings for its first quarter.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/12/36337879/how-to-earn-500-a-month-from-broadcom-stock-following-recent-rally"> How To Earn $500 A Month From Broadcom Stock Following Recent Rally</a>

3 Minutes To Boost Your Earnings: 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts

Dividend Champion, Contender, And Challenger Highlights: Week Of February 18

This week, several dividend stocks are trading close to their 52-week lows. Here is a list of ten such stocks that are also reaching their ex-divid...

Ex-Dividend Date Nearing for These 10 Stocks – Week of February 19, 2024

Nu Skin goes ex dividend today

Nu Skin pares some of earlier gain amid activist speculation

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Dividends that provide a passive source of revenue for investors often seem great on the surface. Stocks with high yields can sometimes indicate a company&rsquo;s instability or solely serve the purpose of attracting investors without offering sustainable returns.



The three stocks we&rsquo;ll introduce in this article have very high dividends but shaky financials and past troubles with cuts. Investors should be aware of the real picture behind the attractive dividend rates that these companies proclaim.



To better understand these stocks, we&rsquo;ll detail their long-term performances, any significant changes made to their dividend rates, and relevant financial history.



<h2>Icahn Enterprises (IEP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/iep1600-300x169.png" alt="Icahn Enterprises Conglomerate company logo seen displayed on smart phone. IEP stock"><div>Source: IgorGolovniov / Shutterstock.com</div></div>Icahn Enterprises (NASDAQ:<a href="https://investorplace.com/stock-quotes/iep-stock-quote/">IEP</a>) is the company of Carl Icahn, a well-known investor. Despite a history of large payouts, it has seen a lot of scrutiny in its time. Troubles that Icahn Enterprises has faced include a <a href="https://www.wsj.com/articles/icahn-enterprises-under-investigation-by-federal-prosecutors-18f231fd">federal investigation</a> for fraud. This is a questionable trend by short-sellers who profit from a stock&rsquo;s poor performance.



After the investigation was announced last May, Icahn Enterprises&rsquo; stock price took a <a href="https://finance.yahoo.com/quote/IEP">significant hit</a>. It dropped from its $50 base to its current&nbsp;$17 low. This is still reflected in <a href="https://investorplace.com/stock-quotes/iep-stock-quote/">IEP</a>&rsquo;s current price.



As a result of this poor performance, Icahn Enterprises offers a forward yield of 22.90%, a <a href="https://apnews.com/article/icahn-stock-hindenburg-short-selling-report-ca1eb5f2c1269ee20d7f7d7963379a8a">significant cut</a> from its more than 30% yield from a year ago. The negative performance has also attracted the attention of short-sellers who regularly take advantage of the downward trends that affect it.



With the current state of Icahn Enterprises and its ability to provide investors with promised returns, you should think twice before buying or keeping this stock.



<h2>Nu Skin Enterprises (NUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/skincare-1600-300x169.jpg" alt="woman smiling with white background"><div>Source: Odua Images via Shutterstock</div></div>Currently, Nu Skin Enterprises (NYSE:<a href="https://investorplace.com/stock-quotes/nus-stock-quote/">NUS</a>) has a forward yield of 11.77%. But, the company&rsquo;s <a href="https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0001021561/000114036124008111/ef20015265_10k.htm">financials</a> from the past year indicate payouts are unlikely to be sustainable.



In fact, Nu Skin Enterprises has paid out over <a href="https://stockanalysis.com/stocks/nus/dividend/">130% of its profit</a> yet was still forced to make quarterly dividend cuts. And this year, it is experiencing negative dividend growth. The company is not making more than it is paying. So payouts are unlikely for its current dividend yield.



Part of these cuts come from a year-over-year (YOY) <a href="https://www.macrotrends.net/stocks/charts/NUS/nu-skin-enterprises/revenue">revenue decline</a> of near 6%. Additionally, the company&rsquo;s <a href="https://www.sltrib.com/news/business/2023/12/18/nu-skin-lays-off-staff-after/">layoffs last November</a> were part of a restructuring project. These terminations were a direct result of the company&rsquo;s poor performance in last year&rsquo;s Q3.



With Nu Skin Enterprises&rsquo; current low, investors should understand the possibility of further dividend cuts. Think twice before buying NUS simply for the high yield.



<h2>AT&amp;T (T)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/att-t-stock1600-300x169.png" alt="AT&amp;T Retail cell phone and mobility store. T stock"><div>Source: Jonathan Weiss / Shutterstock.com</div></div>Possibly the largest worldwide telecommunications companies, AT&amp;T (NYSE:<a href="https://investorplace.com/stock-quotes/t-stock-quote/">T</a>) offers a dividend yield of 6.52%. By comparison, the S&amp;P 500 average is 2%. However, AT&amp;T&rsquo;s <a href="https://about.att.com/story/2024/q4-earnings-2023.html#:~:text=Fourth%20quarter%20revenues%20of%20%2432.0,up%205.0%25%20year%20over%20year.)">Q4 report</a> included a -$0.07 drop in earnings per share YOY.



Even though revenue was up in 2023 YOY, the company continues facing daunting <a href="https://companiesmarketcap.com/att/total-debt/#:~:text=Total%20debt%20on%20the%20balance,current%20and%20non%2Dcurrent%20debts.)">debt of over $150 billion</a> with rising interest rates. High debt is accompanied by the risk that AT&amp;T will not be able to pay the high dividend it promises.



In addition to lower-than-expected earnings last year, AT&amp;T hasn&rsquo;t <a href="https://ycharts.com/companies/T/total_return_price">performed</a> in line with the S&amp;P 500 average in total returns. It&rsquo;s never been an outstanding performer for investors in the past. Therefore, despite promises of high yields, the safety of those dividends should be called into question.



On the date of publication, Joel Lim did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Joel Lim is a finance freelance writer who writes content for several companies like LTSE and Realtor, along with financial publications, including Mises Institute and Foundation for Economic Education.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/high-yield-dividend-stocks-to-avoid-3-dangerous-picks/">High-Yield Dividend Stocks to Avoid: 3 Dangerous Picks</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

High-Yield Dividend Stocks to Avoid: 3 Dangerous Picks

Nu Skin Enterprises (NUS) just unveiled an update. Andrew Lipman has announced his retirement from the Nu Skin Enterprises, Inc. Board of Directors...

Andrew Lipman Retires from Nu Skin Board of Directors

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Dividends that provide a passive source of revenue for investors often seem great on the surface. Stocks with high yields can sometimes indicate a company&rsquo;s instability or solely serve the purpose of attracting investors without offering sustainable returns.



The three stocks we&rsquo;ll introduce in this article have very high dividends but shaky financials and past troubles with cuts. Investors should be aware of the real picture behind the attractive dividend rates that these companies proclaim.



To better understand these stocks, we&rsquo;ll detail their long-term performances, any significant changes made to their dividend rates, and relevant financial history.



<h2>Icahn Enterprises (IEP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/iep1600-300x169.png" alt="Icahn Enterprises Conglomerate company logo seen displayed on smart phone. IEP stock"><div>Source: IgorGolovniov / Shutterstock.com</div></div>Icahn Enterprises (NASDAQ:<a href="https://investorplace.com/stock-quotes/iep-stock-quote/">IEP</a>) is the company of Carl Icahn, a well-known investor. Despite a history of large payouts, it has seen a lot of scrutiny in its time. Troubles that Icahn Enterprises has faced include a <a href="https://www.wsj.com/articles/icahn-enterprises-under-investigation-by-federal-prosecutors-18f231fd">federal investigation</a> for fraud. This is a questionable trend by short-sellers who profit from a stock&rsquo;s poor performance.



After the investigation was announced last May, Icahn Enterprises&rsquo; stock price took a <a href="https://finance.yahoo.com/quote/IEP">significant hit</a>. It dropped from its $50 base to its current&nbsp;$17 low. This is still reflected in <a href="https://investorplace.com/stock-quotes/iep-stock-quote/">IEP</a>&rsquo;s current price.



As a result of this poor performance, Icahn Enterprises offers a forward yield of 22.90%, a <a href="https://apnews.com/article/icahn-stock-hindenburg-short-selling-report-ca1eb5f2c1269ee20d7f7d7963379a8a">significant cut</a> from its more than 30% yield from a year ago. The negative performance has also attracted the attention of short-sellers who regularly take advantage of the downward trends that affect it.



With the current state of Icahn Enterprises and its ability to provide investors with promised returns, you should think twice before buying or keeping this stock.



<h2>Nu Skin Enterprises (NUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/skincare-1600-300x169.jpg" alt="woman smiling with white background"><div>Source: Odua Images via Shutterstock</div></div>Currently, Nu Skin Enterprises (NYSE:<a href="https://investorplace.com/stock-quotes/nus-stock-quote/">NUS</a>) has a forward yield of 11.77%. But, the company&rsquo;s <a href="https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0001021561/000114036124008111/ef20015265_10k.htm">financials</a> from the past year indicate payouts are unlikely to be sustainable.



In fact, Nu Skin Enterprises has paid out over <a href="https://stockanalysis.com/stocks/nus/dividend/">130% of its profit</a> yet was still forced to make quarterly dividend cuts. And this year, it is experiencing negative dividend growth. The company is not making more than it is paying. So payouts are unlikely for its current dividend yield.



Part of these cuts come from a year-over-year (YOY) <a href="https://www.macrotrends.net/stocks/charts/NUS/nu-skin-enterprises/revenue">revenue decline</a> of near 6%. Additionally, the company&rsquo;s <a href="https://www.sltrib.com/news/business/2023/12/18/nu-skin-lays-off-staff-after/">layoffs last November</a> were part of a restructuring project. These terminations were a direct result of the company&rsquo;s poor performance in last year&rsquo;s Q3.



With Nu Skin Enterprises&rsquo; current low, investors should understand the possibility of further dividend cuts. Think twice before buying NUS simply for the high yield.



<h2>AT&amp;T (T)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/att-t-stock1600-300x169.png" alt="AT&amp;T Retail cell phone and mobility store. T stock"><div>Source: Jonathan Weiss / Shutterstock.com</div></div>Possibly the largest worldwide telecommunications companies, AT&amp;T (NYSE:<a href="https://investorplace.com/stock-quotes/t-stock-quote/">T</a>) offers a dividend yield of 6.52%. By comparison, the S&amp;P 500 average is 2%. However, AT&amp;T&rsquo;s <a href="https://about.att.com/story/2024/q4-earnings-2023.html#:~:text=Fourth%20quarter%20revenues%20of%20%2432.0,up%205.0%25%20year%20over%20year.)">Q4 report</a> included a -$0.07 drop in earnings per share YOY.



Even though revenue was up in 2023 YOY, the company continues facing daunting <a href="https://companiesmarketcap.com/att/total-debt/#:~:text=Total%20debt%20on%20the%20balance,current%20and%20non%2Dcurrent%20debts.)">debt of over $150 billion</a> with rising interest rates. High debt is accompanied by the risk that AT&amp;T will not be able to pay the high dividend it promises.



In addition to lower-than-expected earnings last year, AT&amp;T hasn&rsquo;t <a href="https://ycharts.com/companies/T/total_return_price">performed</a> in line with the S&amp;P 500 average in total returns. It&rsquo;s never been an outstanding performer for investors in the past. Therefore, despite promises of high yields, the safety of those dividends should be called into question.



On the date of publication, Joel Lim did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Joel Lim is a finance freelance writer who writes content for several companies like LTSE and Realtor, along with financial publications, including Mises Institute and Foundation for Economic Education.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/high-yield-dividend-stocks-to-avoid-3-dangerous-picks/">High-Yield Dividend Stocks to Avoid: 3 Dangerous Picks</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Cosmetics stocks slump after Ulta Beauty warns on beauty sales slowdown

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Finding the possible painful investment in the turbulent current market is essential to protecting the financial future. Investors should pay close attention to these three stocks because of their weaknesses. Even though every firm works in a different industry, they face the same difficulties in an unpredictable economy. This has all resulted in several stocks to ditch that you need to drop soon. 



The enormous losses incurred by the first demonstrate the adverse effects of high operational costs and judicial proceedings on financial performance. The second one struggles with unclear regulations. This highlights the cryptocurrency market&rsquo;s volatility and significantly impacts its topline.



Lastly, the third one has revenue struggles in unstable economic regions. This is indicative of larger macroeconomic issues that impact consumer purchasing. The general state of the economy is still unstable. To counter this, the company made attempts to change its approach to the market and establish stability in some areas. As a result, estimates for future sales and profitability are cautious.



Take a closer look at each stock&rsquo;s fundamentals, analyze the variables influencing its risks, and learn why selling these assets is necessary to reduce possible losses in the following parts.



<h2>Trump Media &amp; Technology (DJT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/03/dwac1600-300x169.png" alt="In this photo illustration, the Truth Social logo seen displayed on a smartphone with a photo of former US President Donald Trump displayed in the background. DJT stock"><div>Source: rafapress / Shutterstock.com</div></div>Trump Media &amp; Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) has reported substantial net losses. Compared to the prior year&rsquo;s loss of&nbsp;<a href="https://ir.tmtgcorp.com/news-events/press-releases/#b2iLibScrollTo" target="_blank">$15,642,548</a>&mdash;a significant increase&mdash;the company&rsquo;s net loss for 2023 was $21,890,641. Numerous variables, such as high operational costs, expenses associated with legal investigations, and income taxes, might be blamed for these losses.



Moreover, Trump Media &amp; Technology&rsquo;s ineffective use of capital is a serious flaw that jeopardizes company earnings and prospects. The company&rsquo;s fundraising efforts and business operations resulted in significant transaction costs, including underwriting fees and other offering charges, totaling $15,668,029.



Furthermore, net losses and operating liabilities accounted for most of the $5,135,588 in cash spent on operating activities in 2023. These cash outflows show that the business is dependent on outside funding sources.



Overall, capital allocation and financial resource management inefficiencies threaten Trump Media &amp; Technology&rsquo;s profitability and long-term valuations. Lastly, cash outflows deplete the company&rsquo;s financial resources and restrict its capacity to pursue growth prospects. Similarly, high transaction costs threaten the company&rsquo;s bottom line and valuation. Needless to say, this is easily one of the stocks to ditch you need to drop soon. 



<h2>Coinbase (COIN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/02/coin-eth1600-300x169.png" alt="Coinbase (COIN), is an American company that operates a cryptocurrency exchange platform. Ethereum (ETH-USD) coin on the background of the Coinbase inscription."><div>Source: Sergei Elagin / Shutterstock.com</div></div>Legal issues and regulatory ambiguity plague Coinbase (NASDAQ:<a href="https://investorplace.com/stock-quotes/coin-stock-quote/">COIN</a>), as seen by the Securities and Exchange Commission&rsquo;s ongoing enforcement action. Even if the courts are being used to seek regulatory clarity, the conclusion still needs to be discovered, and the legal procedure may take longer than expected.&nbsp;



Additionally, this regulatory ambiguity seriously jeopardizes Coinbase&rsquo;s business operations and future development possibilities. Long-running legal disputes can be expensive, take up management time, and cause investor and consumer concern. Moreover, governmental oversight may make it more difficult for Coinbase to <a href="https://s27.q4cdn.com/397450999/files/doc_financials/2023/q4/Coinbase-Q4-23-Earnings-Call-Transcript.pdf">launch new services</a>&nbsp;and products, enter new markets, or establish profitable alliances.



Furthermore, conditions in the cryptocurrency market, like price volatility and trading activity, significantly impact Coinbase&rsquo;s financial success. Changes in cryptocurrency values directly impact asset inflows and balances, transaction income, subscription and service revenue, and market sentiment. This dependence on crypto market conditions introduces inherent volatility and uncertainty into Coinbase&rsquo;s revenue and profitability.&nbsp;



In short, while major price swings or corrections in the cryptocurrency market might result in lower income and monetary losses, a strong market can also stimulate more trading activity and&nbsp;<a href="https://s27.q4cdn.com/397450999/files/doc_financials/2023/q4/Coinbase-Q4-23-Earnings-Call-Transcript.pdf" target="_blank">revenue growth</a>. Make sure you get rid of this and the other stocks to ditch we mentioned. 



<h2>Nu Skin (NUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/skincare-1600-300x169.jpg" alt="woman smiling with white background"><div>Source: Odua Images via Shutterstock</div></div>Geographical difficulties and market volatility affect Nu Skin&rsquo;s (NYSE:<a href="https://investorplace.com/stock-quotes/nus-stock-quote/">NUS</a>) sales performance. The Americas, South Korea, Europe, Southeast Asia, and other regions hit by prolonged hyperinflationary conditions put pressure on consumer spending in the near term.



In detail, Nu Skin claimed&nbsp;<a target="_blank" href="https://www.nuskin.com/content/corpcom/en_US/newsroom/press_releases1/2024/nu-skin-enterprises-reports-fourth-quarter-and-full-year-2023-re.html">stabilization in Mainland China</a>&nbsp;in the fourth quarter of 2023 despite difficulties in several regions, which they blamed on seasonal promotions. Nonetheless, as the economy attempts to recover, the company expects further difficulties in the Chinese market. Nu Skin intends to&nbsp;<a target="_blank" href="https://seekingalpha.com/article/4670340-nu-skin-enterprises-inc-nus-q4-2023-earnings-call-transcript">work with Douyin</a>, a TikTok sister app, to launch a new go-to-market strategy in Mainland China in response to market instability and to adjust to shifting customer tastes and behaviors.



Moreover, given the uncertainty surrounding macroeconomic conditions and the company&rsquo;s transformation activities, Nu Skin gave cautious&nbsp;<a href="https://seekingalpha.com/article/4670340-nu-skin-enterprises-inc-nus-q4-2023-earnings-call-transcript" target="_blank">guidance for 2024.</a>&nbsp;The estimated revenue range in 2024 is between $1.73 billion and $1.87 billion, and sales of $400 million to $435 million for Q1 2024.



Finally, in light of continuous macroeconomic headwinds, corporate transformation initiatives, and difficulties in attaining profitability, the company also projects negative profits per share, including restructuring costs.



On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.<a href="https://investorplace.com/stock-quotes/-stock-quote/"></a>
<div>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/crash-course-3-stocks-to-ditch-before-the-economy-sinks/">Crash Course: 3 Stocks to Ditch Before the Economy Sinks</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.